OPRX News and Press, OptimizeRx Corporation From 05/10/22

ROCHESTER, Mich., May 10, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that management will participate in the RBC H...

A lot of small biotechs are fantastic buys right now. With Big Pharma sitting on a lot of cash, we might start seeing some smart acquisitions later this year. We asked a trio of contributors to pick the biotechs they're feeling most bullish about as potential buyout candidates in 2022. ...

OptimizeRx Corporation (OPRX) Q1 2022 Earnings Conference Call May 04, 2022, 04:30 PM ET Company Participants William Febbo - Chief Executive Officer Ed Stelmakh - Chief Financial Officer & Chief Operating Officer Andrew D’Silva - Senior Vice President of Corporate Finance Conferen...

OptimizeRx press release (NASDAQ:OPRX): Q1 Non-GAAP EPS of -$0.01 in-line. Revenue of $13.73M (+22.3% Y/Y) beats by $0.18M. Outlook: The Company is reaffirming its full year financial outlook for 2022 and continues to expect net revenues of $80 million to $85 million, representing year-over-y...

Revenue Up 22% to $13.7 million on increased average revenue per top 20 pharmaceutical manufacturer client Traction with top 20 pharmaceutical manufacturers continues to advance and drive growth Cash flow positive from operations of $4.1 million ROCHESTER, Mich., May 04, 2...

ROCHESTER, Mich., April 29, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy has published its first Environmental, Social and Governan...

ROCHESTER, Mich., April 21, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, will hold a conference call on Wednesday, May 4, 2022,...

Physicians report that medication access impacts initial therapy choice for some patients and may require changes to preferred treatment plan ROCHESTER, Mich., April 20, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leadin...

1 in 4 say they’ve had to change a treatment plan due to medication access issues, highlighting how access barriers can impact patient care ROCHESTER, Mich., April 19, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a lea...

ROCHESTER, Mich., April 05, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX),  a leading provider of point-of-care technology solutions helping patients start and stay on therapy, has been named to the Financial Times (“FT”)...